Lovastatin promotes myelin formation in NPC1 mutant oligodendrocytes

[1]  D. Lyons,et al.  Ca2+ activity signatures of myelin sheath formation and growth in vivo , 2017, Nature Neuroscience.

[2]  R. Mechelli,et al.  A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials , 2017, Scientific Reports.

[3]  H. Fuchs,et al.  Interplay between H1 and HMGN epigenetically regulates OLIG1&2 expression and oligodendrocyte differentiation , 2016, Nucleic acids research.

[4]  W. Richardson,et al.  Evolution of the CNS myelin gene regulatory program , 2016, Brain Research.

[5]  A. El Manira,et al.  Synaptic vesicle release regulates the number of myelin sheaths made by individual oligodendrocytes in vivo , 2015, Nature Neuroscience.

[6]  W. Macklin,et al.  Olig1 Function Is Required for Oligodendrocyte Differentiation in the Mouse Brain , 2015, The Journal of Neuroscience.

[7]  P. Paez,et al.  Voltage-gated Ca++ entry promotes oligodendrocyte progenitor cell maturation and myelination in vitro , 2015, Experimental Neurology.

[8]  H. Hartung,et al.  Oligodendroglial Maturation Is Dependent on Intracellular Protein Shuttling , 2015, The Journal of Neuroscience.

[9]  M. Vanier.  Complex lipid trafficking in Niemann-Pick disease type C , 2015, Journal of Inherited Metabolic Disease.

[10]  M. Wegner,et al.  The Transcription Factors Sox10 and Myrf Define an Essential Regulatory Network Module in Differentiating Oligodendrocytes , 2013, PLoS genetics.

[11]  C. ffrench-Constant,et al.  Individual Oligodendrocytes Have Only a Few Hours in which to Generate New Myelin Sheaths In Vivo , 2013, Developmental cell.

[12]  J. Chan,et al.  Stage-Specific Deletion of Olig2 Conveys Opposing Functions on Differentiation and Maturation of Oligodendrocytes , 2013, The Journal of Neuroscience.

[13]  A. Lieberman,et al.  Npc1 Acting in Neurons and Glia Is Essential for the Formation and Maintenance of CNS Myelin , 2013, PLoS genetics.

[14]  Hongye Liu,et al.  Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2 , 2012, Nature Reviews Neuroscience.

[15]  H. Luhmann,et al.  Myelin Basic Protein synthesis is regulated by small non‐coding RNA 715 , 2012, EMBO reports.

[16]  M. Hariharan,et al.  Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol , 2011, Journal of neurochemistry.

[17]  M. Frech,et al.  Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse , 2011, Metabolic Brain Disease.

[18]  Tyler Schwend,et al.  Requirement of Npc1 and availability of cholesterol for early embryonic cell movements in zebrafish[S] , 2011, Journal of Lipid Research.

[19]  Eva-Maria Krämer-Albers,et al.  From axon–glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase , 2011, Cellular and Molecular Life Sciences.

[20]  I. Singh,et al.  Activation of PPAR‐γ and PTEN cascade participates in lovastatin‐mediated accelerated differentiation of oligodendrocyte progenitor cells , 2010, Glia.

[21]  Moritz J Frech,et al.  Differentiation of human neural progenitor cells regulated by Wnt-3a. , 2010, Biochemical and biophysical research communications.

[22]  C. Lubetzki,et al.  Axon‐oligodendrocyte interactions during developmental myelination, demyelination and repair , 2010, Journal of neurochemistry.

[23]  Z. Xiang,et al.  Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelination , 2009, Experimental Neurology.

[24]  Ben A. Barres,et al.  Distinct Stages of Myelination Regulated by γ-Secretase and Astrocytes in a Rapidly Myelinating CNS Coculture System , 2008, Neuron.

[25]  Eva-Maria Krämer-Albers,et al.  Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2–dependent RNA granules , 2008, The Journal of cell biology.

[26]  I. Singh,et al.  Inhibition of Rho Family Functions by Lovastatin Promotes Myelin Repair in Ameliorating Experimental Autoimmune Encephalomyelitis , 2008, Molecular Pharmacology.

[27]  P. Watkins,et al.  Roundtable Discussion of Session 2: Lipoproteins and Polyunsaturated Fatty Acids , 2007, Journal of Molecular Neuroscience.

[28]  G. Brewer,et al.  Isolation and culture of adult neurons and neurospheres , 2007, Nature Protocols.

[29]  Jie Peng,et al.  Isolation and culture of rat and mouse oligodendrocyte precursor cells , 2007, Nature Protocols.

[30]  S. Zamvil,et al.  Simvastatin regulates oligodendroglial process dynamics and survival , 2007, Glia.

[31]  J. T. Gonçalves,et al.  Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites , 2006, The Journal of cell biology.

[32]  Palma Iannarelli,et al.  Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage , 2006, Nature Neuroscience.

[33]  L. Steinman,et al.  Drug Insight: using statins to treat neuroinflammatory disease , 2005, Nature Clinical Practice Neurology.

[34]  H. Hartung,et al.  Statins — a cure-all for the brain? , 2005, Nature Reviews Neuroscience.

[35]  Klaus-Armin Nave,et al.  High cholesterol level is essential for myelin membrane growth , 2005, Nature Neuroscience.

[36]  V. Durkalski,et al.  Oral simvastatin treatment in relapsing-remitting multiple sclerosis , 2004, The Lancet.

[37]  R. Pedrosa,et al.  Therapeutic potential of lovastatin in multiple sclerosis , 2003, Journal of Neurology.

[38]  D. German,et al.  Neurodegeneration in the Niemann–Pick C mouse: glial involvement , 2002, Neuroscience.

[39]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[40]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[41]  T. Terasaki,et al.  In Vivo and in Vitro Blood–Brain Barrier Transport of 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors , 1994, Pharmaceutical Research.

[42]  C. Readhead,et al.  The dysmyelinating mouse mutations shiverer (shi) and myelin deficient (shimld) , 1990, Behavior genetics.

[43]  J. de Vellis,et al.  Regulation of myelin basic protein in oligodendrocytes by a soluble neuronal factor , 1986, Journal of neuroscience research.